Management of Electrolyte Abnormalities and Renal Function in Trans Male Patients

Initial Assessment and Management

The American College of Cardiology recommends prompt intervention for hyperkalemia (K+ 5.6 mEq/L) to reduce the risk of cardiac arrhythmias and sudden death, with initial management including IV fluids (0.9% saline) to promote potassium excretion 1
The American Heart Association suggests considering insulin with glucose if potassium remains elevated, as part of the initial management of hyperkalemia 1
The American College of Cardiology advises avoiding medications that can worsen hyperkalemia, including NSAIDs, to prevent further complications 2

The National Comprehensive Cancer Network recommends hydration with IV fluids to increase calcium excretion, as the initial management of hypercalcemia 3
The National Comprehensive Cancer Network suggests considering bisphosphonates if hypercalcemia persists despite hydration, to help normalize calcium levels 3

A current eGFR of 56 mL/min/1.73m² indicates moderate renal impairment, according to the Mayo Clinic Proceedings, and requires careful management to prevent further decline 1
The British Journal of Pharmacology recommends maintaining high urine output (goal 100-150 mL/h) to decrease tubular damage and slow the progression of renal impairment 3
The National Comprehensive Cancer Network advises discontinuing nephrotoxic medications to prevent further renal damage 3
The British Journal of Pharmacology suggests monitoring renal function closely with regular creatinine measurements to promptly detect any changes in renal function 4

The American Heart Association recommends checking serum potassium and renal function within 2-3 days of intervention, and rechecking at 7 days and then monthly for the first 3 months, to ensure that electrolyte abnormalities are resolving 5, 6
The National Comprehensive Cancer Network advises monitoring calcium levels weekly until normalized, to ensure that hypercalcemia is adequately managed 3

The Mayo Clinic Proceedings recommends implementing a low-potassium diet while hyperkalemia persists, to help reduce potassium levels 1
The American Heart Association suggests providing specific dietary counseling on avoiding high-potassium foods, to help patients manage their condition 6
The National Comprehensive Cancer Network advises considering dietary calcium restriction if hypercalcemia persists, to help normalize calcium levels 3

The American Heart Association recommends avoiding medications that can worsen hyperkalemia, such as ACE inhibitors, ARBs, and potassium-sparing diuretics, to prevent further complications 5, 7
The Mayo Clinic Proceedings advises using caution with medications requiring renal clearance in patients with eGFR <60 mL/min/1.73m², to prevent further renal damage 1, 4

The American Heart Association suggests discussing temporary alternatives to injectable testosterone if needed during renal function recovery, to balance gender-affirming hormone needs with renal protection strategies 6
The American Heart Association recommends balancing gender-affirming hormone needs with renal protection strategies, to ensure that patients receive comprehensive care 5

The British Journal of Pharmacology recommends referring patients to nephrology if renal function continues to deteriorate (further decrease in eGFR), to provide specialized care 4
The Mayo Clinic Proceedings advises referring patients to nephrology if hyperkalemia persists despite conservative management, to provide further evaluation and treatment 1
The National Comprehensive Cancer Network recommends referring patients to nephrology if hypercalcemia does not respond to initial treatment, to provide comprehensive evaluation and management 3